NCT03880825View on ClinicalTrials.gov

Drug Interaction Study of Levoketoconazole and Metformin

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

May 3, 2019

Study Completion Date

May 3, 2019

Conditions

Healthy Subjects

Interventions

DRUG

Metformin 500 mg Oral Tablet

single dose

DRUG

Levoketoconazole 150 - 600 mg (BID)

escalating dose from 150 mg to 600 mg (BID)

Trial Locations (1)

33014

Clinical Pharmacology of Miami, LLC, Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Cortendo AB

INDUSTRY